Rheumatology diseases affects the supporting or connecting structures of the body mostly joints, ligaments, muscles, tendons, and rarely some organs of the body. This disease is characterized by inflammation of joints and it affects spine in some types of rheumatology disease. There are more than 100 types of rheumatic disease. It is caused by various genetic and environmental factors, such as unhealthy diet and changing lifestyle, which can lead to rheumatology diseases. Osteoarthritis, ankylosing spondylitis, rheumatoid arthritis, gout, psoriatic arthritis, reactive arthritis, fibromyalgia, and scleroderma are some of the common types of rheumatology diseases. Rheumatology treatment involves medications, exercises, and physical therapies with surgical treatment to cure joint damage. Early treatment can be beneficial for treatment of rheumatologic symptoms. Physicians prescribe disease-modifying antirheumatic drugs (DMARD’s) for the treatment of rheumatologic disease. Sufficient nutrition, proper exercise, and medications can help to cure rheumatology diseases.

Increasing burden of rheumatology diseases globally is propelling the growth of rheumatology therapeutics market

The increase in population with some sort of rheumatology arthritis globally is major driving factor for the rheumatology therapeutics market. According to data given by Centers for Disease Control and Prevention (CDC) in 2013, around 52.5 million of adults in the U.S. have suffered from rheumatology arthritis, which equals to 23% of the population with 1% being the prevalence rate of rheumatology diseases globally. According to the Global Burden of Disease 2010 study data, prevalence rate for knee arthritis globally was 3.8% and for hip osteoarthritis was 0.85% globally. Additionally, technological advancements in medical field, investments in the healthcare sector over research and development, and rising trend of fitness are important factors contributing to the growth of rheumatology therapeutics market. According to the World Health Organization (WHO) in 2014, government spent 15.5% on healthcare sector.

However, introduction of biosimilars is major restraint for rheumatology therapeutics market.  Increasing demand for biosimilar may hinder the conventional drug commonly used for rheumatology diseases treatment. Patent expiry of some drugs used in the treatment of rheumatology diseases is also hampering the growth of rheumatology therapeutics market. For instance, patent expiry of Enbrels drug in 2012.

Rheumatoid arthritis holds the largest share due to high prevalence rate in the rheumatology therapeutics market

The global rheumatology therapeutics market is segmented by disease type, by drug type, by end user, and by region

On the basis of disease type, the rheumatology therapeutics market is segmented into:

  • Osteoarthritis
  • Ankylosing spondylitis
  • Rheumatoid arthritis
  • Gout
  • Psoriatic arthritis
  • Reactive arthritis
  • Fibromyalgia
  • Scleroderma
  • Others

On the basis of drug type, the rheumatology therapeutics market is segmented into:

  • Disease Modifying Antirheumatic Drugs (DMAD’s)
  • Humira
  • Remicade
  • Cyclosporine
  • Methotrexate
  • Biologics
  • Tofacitinib
  • Others

On the basis of end user, the rheumatology therapeutics market is segmented into:

  • Hospitals
  • Medical clinics

Established healthcare sector of North America is contributing to the leading position of this region in rheumatology therapeutics market

Regional segmentation of rheumatology therapeutics market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America dominates rheumatology therapeutics market, owing to increasing population with rheumatology diseases, changing lifestyle, and established medical and healthcare sector. According to Centers for Disease Control and Prevention (CDC), around 27 million people are suffering with Clinical arthritis in the U.S, around 8 million people with Gout syndrome, and 78 million adults are at risk to suffer from clinical arthritis till 2040. Asia Pacific is expected to witness the growth in the rheumatology therapeutics market due to increase in patient population and developing healthcare sector.

The key players are involved in doing licensing agreement with other manufacturers to hold the major market share in rheumatology therapeutics market

Key industry players operating the rheumatology therapeutics market includes AstraZeneca, Rigel pharma, Abbott Laboratories, Pfizer, Amgen, Janssen Biotech, Merck Co. Inc., Eli Lily, and Alder Biopharmaceuticals. Key players are involved in the acquisitions and agreement with other companies to hold the maximum share. For instance, licensing agreement of Bri Stol-Myers Squibb with Alder Biopharmaceuticals Company and the major acquisition of Ardea Biosciences by AstraZeneca are one of the important agreements between 2007 and 2012.


Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.

Data Triangulation Methodology | Coherent Market Insights

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Market Analysis | Coherent Market Insights

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users